Albemarle Corporation (ALB) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $189.86. It has a SharesGrow Score of 38/100, indicating a weak investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ALB = $315.83 (+66.3% from the current price, the stock appears undervalued). Analyst consensus target is ALB = $186 (-2.1% upside).
Valuation: ALB trades at a trailing Price-to-Earnings (P/E) of -41.1 (S&P 500 average ~25).
Financials: revenue is $5.1B, -5.7%/yr average growth. Net income is $511M (loss), growing at -47.1%/yr. Net profit margin is -9.9% (negative). Gross margin is 13.1% (-28.9 pp trend).
Balance sheet: total debt is $3.3B against $9.5B equity (Debt-to-Equity (D/E) ratio 0.35, conservative). Current ratio is 2.23 (strong liquidity). Debt-to-assets is 20.1%. Total assets: $16.4B.
Analyst outlook: 19 / 45 analysts rate ALB as buy (42%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 64/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 67/100 (Partial), Moat 37/100 (Fail), Future 26/100 (Fail), Income 10/100 (Fail).
